Review of the clinical development of fexuprazan for gastroesophageal reflux–related disease
Crossref DOI link: https://doi.org/10.1007/s00228-023-03521-4
Published Online: 2023-06-22
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ramani, Azaan
Merchant, Alisha
Cash, Brooks D.
Text and Data Mining valid from 2023-06-22
Version of Record valid from 2023-06-22
Article History
Received: 10 April 2023
Accepted: 4 June 2023
First Online: 22 June 2023
Declarations
:
: Not applicable.
: The authors declare no competing interests.